Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study.

Nyckelord

Administration; Cutaneous

Aged

Antibodies; Monoclonal/administration & dosage

Anticoagulants/*administration & dosage

Aspirin/administration & dosage

Blood Flow Velocity

Chemotherapy; Adjuvant

Comparative Study

Coronary Angiography

Drug Therapy; Combination

Female

Heparin/*administration & dosage

Heparin; Low-Molecular-Weight/administration & dosage

Humans

Immunoglobulins; Fab/administration & dosage

Infusions; Intravenous

Male

Myocardial Infarction/*drug therapy

Myocardial Revascularization

Platelet Aggregation Inhibitors/administration & dosage

Recurrence

Research Support; Non-U.S. Gov't

Tedelparin/administration & dosage

Tissue Plasminogen Activator/*administration & dosage

Treatment Outcome

Vascular Patency

MEDICINE

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)